Connect with us
European Gaming Congress 2024

Artificial Intelligence

NIO Inc. Provides February 2020 Delivery Update

Published

on

Delivered 707 vehicles in February 2020
Delivered 2,305 vehicles in 2020 in total
Cumulative deliveries of ES8 and ES6 reached 34,218SHANGHAI, China, March 10, 2020 (GLOBE NEWSWIRE) — NIO Inc. (“NIO” or the “Company”) (NYSE: NIO), a pioneer in China’s premium electric vehicle market, today provided its February 2020 delivery results.NIO delivered 707 vehicles in February 2020, consisted of 671 ES6s, the Company’s 5-seater high-performance premium electric SUV, and 36 ES8s, the Company’s 7-seater high-performance premium electric SUV and its 6-seater variant. The Company plans to commence deliveries of the new ES8 in April 2020. As of February 29, 2020, cumulative deliveries of the ES8 and the ES6 reached 34,218 vehicles, of which 2,305 vehicles were delivered in 2020.“The novel coronavirus has broken out in China since the end of January 2020. While the overall passenger vehicle sales in China took a hit and slumped over 78% year on year in February 2020, NIO’s deliveries had declined by 12.8% year on year for the same period,” said William Bin Li, founder, chairman and chief executive officer of NIO. “Deliveries have been constrained as services are being cautiously reopened and people are encouraged to avoid unnecessary close-range contact. In addition, the production has started ramping up gradually from the middle of February and supply chains have remained challenging.“Nevertheless, with most NIO Houses and NIO Spaces staying in full or partial operation, we have aggressively explored a variety of online traffic channels to promote our products, technologies and services to potential users. Our direct sales model, enabled by well-developed purchase functions on the NIO app, has played a critical role in this sales environment. We are pleased to see positive responses from different channels, which are being translated to encouraging order numbers,” concluded Mr. Li.Steven Feng, chief financial officer of NIO, added, “We expect that it will take time for the industry and NIO to resume normal productions. We will keep monitoring and coordinating supply chain resources and accelerate productions to fulfill the growing demand.”About NIO Inc.NIO Inc. is a pioneer in China’s premium electric vehicle market. Founded in November 2014, NIO’s mission is to shape a joyful lifestyle by offering premium smart electric vehicles and being the best user enterprise. NIO designs, jointly manufactures, and sells smart and connected premium electric vehicles, driving innovations in next generation technologies in connectivity, autonomous driving and artificial intelligence. Redefining the user experience, NIO provides users with comprehensive, convenient and innovative charging solutions and other user-centric services. NIO began deliveries of the ES8, a 7-seater high-performance premium electric SUV in China in June 2018, and its variant, the 6-seater ES8, in March 2019. NIO officially launched the ES6, a 5-seater high-performance premium electric SUV, in December 2018 and began the first deliveries of the ES6 in June 2019. NIO officially launched the EC6, a 5-seater smart premium electric coupe SUV, in December 2019 and plans to commence deliveries in 2020.Safe Harbor StatementThis press release contains statements that may constitute “forward-looking” statements pursuant to the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to” and similar statements. Among other things, quotations from management in this announcement, as well as NIO’s strategic and operational plans, contain forward-looking statements. NIO may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about NIO’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: NIO’s strategies; NIO’s future business development, financial condition and results of operations; NIO’s ability to develop and manufacture a car of sufficient quality and appeal to customers on schedule and on a large scale; its ability to grow manufacturing in collaboration with partners; its ability to provide convenient charging solutions to its customers; its ability to satisfy the mandated safety standards relating to motor vehicles; its ability to secure supply of raw materials or other components used in its vehicles; its ability to secure sufficient reservations and sales of the ES8 and ES6; its ability to control costs associated with its operations; its ability to build the NIO brand; general economic and business conditions globally and in China and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in NIO’s filings with the SEC. All information provided in this press release is as of the date of this press release, and NIO does not undertake any obligation to update any forward-looking statement, except as required under applicable law.For more information, please visit: http://ir.nio.comFor investor and media inquiries, please contact:NIO Inc.Investor RelationsTel: +86-21-6908-3474Email: [email protected]Source: NIO

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

DATAMARK Technologies Applauded by Frost & Sullivan for Advancing Location Determination Capabilities and Data Accuracy with Its Improved GIS and Indoor Mapping Solution

Published

on

datamark-technologies-applauded-by-frost-&-sullivan-for-advancing-location-determination-capabilities-and-data-accuracy-with-its-improved-gis-and-indoor-mapping-solution

DATAMARK INSIDE empowers first responders to visualize buildings in 3D, pinpoint the floor levels of 911 callers, and improve situational awareness for more precise and efficient emergency response planning and management.
SAN ANTONIO, Sept. 16, 2024 /PRNewswire/ — Frost & Sullivan researched the indoor mapping industry and, based on its analysis, recognizes DATAMARK Technologies with the 2024 North American New Product Innovation Award. The company combines the expertise of Michael Baker’s public safety and GIS data management capabilities with Digital Data Technologies, Inc.’s top-tier Next Generation 911 location services. The unified brand offers an integrated solution that enhances call routing accuracy, provides seamless discrepancy resolution, and ensures high location fidelity for call takers. By leveraging advanced technologies such as indoor mapping, light detection and ranging (LiDAR), and digital twin technology, the company positions itself to serve the government technology and public safety market with unparalleled data accuracy and interoperability. INSIDE™, DATAMARK’s cloud-native indoor mapping solution, revolutionizes building safety by integrating precise indoor data with tools for effective exit planning, emergency asset access, and incident response.

DATAMARK’s advanced indoor mapping platform allows users to visually manage, update, and collaborate on highly accurate indoor information, enhancing situational awareness and operational efficiency. INSIDE transforms indoor maps into actionable intelligence by creating a common operating picture for public safety stakeholders and facility managers. It empowers first responders to plan efficient entry and exit routes, swiftly access equipment, and precisely locate incidents. With 360-degree imagery and closed-circuit television integration features, INSIDE provides a detailed virtual view of every room, aiding faster wayfinding and coordination. The platform supports collaboration through a role-based interface, permitting multiple users to access and utilize indoor mapping data from smartphones, tablets, or computers. INSIDE’s real-time integration with security camera footage enables public safety personnel to assess incidents before arriving on-site, improving response effectiveness and spatial awareness.
Brent Iadarola, vice president at Frost & Sullivan, observed, “DATAMARK’s innovative approach to real-time GIS data management and integration significantly enhance decision-making and response times in public safety operations. The company sets a new standard for data accuracy and interoperability in the indoor mapping market by leveraging advanced technologies and ensuring comprehensive, scalable, and secure solutions.”
DATAMARK’s INSIDE platform integrates high-quality data with industry-standard GIS systems for seamless connectivity with public safety systems. It addresses the limitations of outdated, paper-based building plans by offering up-to-date digital data accessible to all authorized personnel. The critical information flows seamlessly to those who need it, optimizing asset management, enhancing situational awareness, and enabling efficient emergency responses when every second counts. DATAMARK’s primary differentiator is the ability to manage access to sensitive data securely. Its system permits credential-based access, ensuring only authorized personnel can view and update data. This controlled access is vital when dealing with critical infrastructure and sensitive information, providing security and flexibility in data management. The company’s comprehensive and scalable solutions, its cost-effective and efficient skeletal data collection and management approach, and its emphasis on the importance of sustainable data management also set it apart in the industry.
“DATAMARK’s INSIDE™ allows real-time updates to indoor mapping data, ensuring all stakeholders access the most current and accurate information. This feature enhances operational efficiency by dynamically updating floor plans and critical data across all integrated systems, including computer-aided dispatch and emergency management platforms. By promptly addressing user needs and integrating their suggestions, DATAMARK continually refines its solutions to better serve its clients’ evolving requirements,” added Ojaswi Rana, best practices research analyst at Frost & Sullivan.
Each year, Frost & Sullivan presents this award to the company that has developed an innovative element in a product by leveraging leading-edge technologies. The award recognizes the value-added features/benefits of the product and the increased return on investment (ROI) it gives customers, which, in turn, raises customer acquisition and overall market penetration potential.
Frost & Sullivan Best Practices awards recognize companies in various regional and global markets for demonstrating outstanding achievement and superior performance in leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analyses, and extensive secondary research to identify best practices in the industry.
About Frost & Sullivan
For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion. Contact us: Start the discussion.
Contact:
Camila TinajeroP: +54911 6713 2748E: [email protected]
Logo – https://mma.prnewswire.com/media/2505170/DATAMARK_Technologies__Award.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/datamark-technologies-applauded-by-frost–sullivan-for-advancing-location-determination-capabilities-and-data-accuracy-with-its-improved-gis-and-indoor-mapping-solution-302247953.html

Continue Reading

Artificial Intelligence

Lab Automation Market to Reach $11.31 Billion by 2031, Driven by Rising Pharmaceutical & Biotech R&D Expenditures and Increasing Demand for Automated Laboratories and Instruments – Report by Meticulous Research®

Published

on

lab-automation-market-to-reach-$11.31-billion-by-2031,-driven-by-rising-pharmaceutical-&-biotech-r&d-expenditures-and-increasing-demand-for-automated-laboratories-and-instruments-–-report-by-meticulous-research

REDDING, Calif., Sept. 16, 2024 /PRNewswire/ — According to a new market research report titled, ‘Lab Automation Market Size, Share, Forecast, & Trends Analysis by Product (Liquid Handling, Nucleic Acid Purification System, Microplate Reader, ELISA, LIMS, ELN), Application (Drug Discovery, Diagnostics, Genomics),End User—Global Forecast to 2031.

The lab automation market is projected to reach $11.31 billion by 2031, at a CAGR of 7.3% from 2024 to 2031.
Download FREE PDF Brochure Of Lab Automation Market – https://www.meticulousresearch.com/pressrelease/967/lab-automation-market-2031
Rising pharmaceutical and biotech R&D expenditures, the increasing demand for automated laboratories and instruments, the high prevalence of chronic and infectious diseases, and initiatives supporting life sciences R&D are driving the growth of the lab automation market. However, the high costs of advanced lab automation equipment and funding & infrastructure limitations in developing countries are factors restraining the growth of this market.
Furthermore, growth in genomics & proteomics research, the increasing focus on food safety & quality, rising awareness & growing adoption of personalized medicines, and emerging economies are expected to generate growth opportunities for the players operating in the lab automation market. However, equipment maintenance & repair and data security & privacy concerns are major challenges impacting market growth.
Get Insightful Data On Regions, Market Segments, Customer Landscape, And Top Companies (Charts, Tables, Figures And More) – https://www.meticulousresearch.com/download-sample-report/cp_id=1221
Automated Laboratories: Effective Management of Clinical Workflows
Lab automation is being widely adopted in clinical laboratories to increase accuracy and efficiency and reduce costs and errors. In the field of medicine, a diagnostic error can incur very high costs. Hence, automating clinical laboratories can significantly reduce human errors and associated costs.
Automating clinical laboratories can have a positive impact on patient outcomes. Quick and reliable diagnostic results allow medical professionals to initiate appropriate treatments, improving the chances of patient survival. Additionally, limited resources, long waiting times for diagnostic results, and the shortage of skilled laboratory staff can lead to poor patient outcomes. The implementation of lab automation in clinical laboratories helps mitigate these issues and provides quick and reliable results, improving patient outcomes.
In the U.S., an estimated 10–20% of diagnoses are inaccurate and result in 40,000–80,000 deaths each year. Automation improves the ordering, testing, and reporting of diagnostic tests and ensures higher throughput, increased productivity, efficient use of reagents & materials, and standardization, decreasing errors and improving turnaround times.
Browse In-depth Report Now – https://www.meticulousresearch.com/product/lab-automation-market-1221
The players operating in this market are focused on launching new automated diagnostic instruments. For instance:
In May 2024, Abbott Laboratories (U.S.) launched its GLP Systems Track in India to support the high-volume needs of laboratories.In September 2023, Yourgene Health plc (U.K.) launched the Yourgene MagBench Automated DNA Extraction Instrument and Kit for Noninvasive Prenatal Testing (NIPT) workflows.In June 2023, Becton, Dickinson and Company (U.S.) launched its BD FACSDuet Premium Sample Preparation System for cellular diagnostic applications.In January 2023, QIAGEN N.V. (Netherlands) launched the EZ2 Connect MDx Platform for automated sample processing in diagnostic labs.In May 2022, Becton, Dickinson and Company (U.S.) launched BD COR MX, a fully automated, high-throughput infectious disease molecular diagnostics platform.Lab Automation Market Analysis: Key Segmental Findings
By Product: In 2024, the systems segment is expected to account for the major share of 71.5% of the lab automation market. However, the software segment is expected to grow at the fastest CAGR of 7.4% during the forecast period of 2024–2031.By Application: In 2024, the drug discovery segment is expected to account for the largest share of the market. However, the clinical diagnostics segment is expected to grow at the fastest CAGR during the forecast period of 2024–2031.By End User: In 2024, the pharmaceutical & biotechnology companies’ segment is expected to account for the largest share of 41.0% of the global market.Explore the Key Market Segments Driving Growth (Download Free Sample) – https://www.meticulousresearch.com/download-sample-report/cp_id=1221
Geographic Analysis:
North America Dominates the Global Market
North America is expected to account for the largest share of 40.8% of the lab automation market. In terms of value, in 2024, the U.S. is expected to account for the major share of 92% of the lab automation market in North America. Pharmaceutical companies in the U.S. are at the forefront of adopting cutting-edge technologies, with a strong emphasis on the implementation of lab automation systems to enhance operational efficiency and gain a competitive edge in the pharmaceutical sector. The adoption of lab automation technologies is driven by several factors, including the surging need for high-throughput analysis, increasing investments in research and development, laboratories’ growing need for increased efficiency, precision, and productivity, and the increasing focus on genomics research and genetic testing. These dynamics are boosting the adoption of lab automation across the country. The U.S. has low market barriers for developing and commercializing pharmaceuticals due to the supportive domestic environment. With the availability of government funding for research activities, robust capital markets, and strong academic research in the country, the U.S. is the world’s largest scientific research base, attracting most global venture capital investments in the biotechnology industry.
Asia-Pacific to Witness Rapid Growth
Asia-Pacific is expected to record the fastest growth over the forecast period, with the regional market reaching $2.74 billion by 2031. The high growth of this regional market is driven by the expanding pharmaceutical & biotechnology industries, rapidly improving healthcare infrastructure, growth in pharmaceutical research, and increasing government funding in APAC. The Asia-Pacific region has become one of the most attractive markets for healthcare & life sciences companies worldwide, primarily due to changing demographics and accelerated economic growth in the region. Countries such as China, India, South Korea, and Indonesia are expanding their healthcare infrastructure, driving the demand for laboratory automation.
Have specific research needs? Request a customized research report – https://www.meticulousresearch.com/request-customization/cp_id=1221
In 2024, China is expected to account for the largest share of the lab automation market in Asia-Pacific. The country’s large market share is mainly attributed to government initiatives focusing on research and development, increasing R&D expenditures of pharmaceutical and biopharmaceutical companies, favorable regulatory policies, the rising prevalence of infectious & chronic diseases, the rising geriatric population, and the increased demand for lab automation among clinical laboratories due to increased disease prevalence.
Germany Continues to Dominate the Lab Automation Market in Europe
In 2024, Germany is expected to account for the largest share of the lab automation market in Europe. Factors such as increasing government investments in the pharmaceutical industry, growing biotech & pharmaceutical R&D expenditures, rising healthcare spending, increasing sample volumes in laboratories due to the rising incidence of chronic and infectious diseases, the increased demand for precision medicines, and the rising focus on genomics research contribute to the country’s largest market share. Germany has a favorable environment for developing and producing research-intensive, high-grade products. According to German Trade & Invest, in 2021, the pharmaceutical industry in Germany invested over $9.1 billion (€7.7 billion) in research and development. Additionally, the government and funding organizations have pledged to substantially increase public & private R&D spending and researchers by 2030 as part of the country’s Sustainable Development Goals (SDG). Thus, increasing government funding for research, the wide availability of technologically advanced laboratory informatics solutions, and laboratories’ need to reduce errors, and associated costs are expected to drive the growth of the lab automation market in Germany.
Need Insights on Regional Data? Check Out Our Detailed Analysis (Download Free Sample) – https://www.meticulousresearch.com/download-sample-report/cp_id=1221
Lab Automation Market: Competition Analysis
This report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios, geographic presence, and key growth strategies adopted over the past 3–4 years. Major companies in the lab automation market have implemented various strategies to expand their product offerings and global footprints and augment their market shares. The key strategies followed by most companies in the lab automation market include product launches, product enhancements, approvals, partnerships, collaborations, agreements, acquisitions, and expansions. The key players operating in the lab automation market include Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.).
Learn About the Top Companies Influencing Market Dynamics (Download Free Sample) – https://www.meticulousresearch.com/download-sample-report/cp_id=1221
Lab Automation Industry Overview: Latest Developments from Key Industry Players
In July 2024, INPECO SA (Switzerland) launched FlexLab X, a next-generation total lab automation system (TLA), at the Annual Scientific Meeting of the Association for Diagnostics & Laboratory Medicine (ADLM 2024). This system can combine analyzers from different vendors, enable space-saving layouts, offers a sleek graphical user interface, and streamlines workflows.In February 2024, Carbon, Inc. (U.S.) launched its Automatic Operation (AO) suite of solutions designed to meet the needs of dental labs, setting new standards in lab automation.In September 2023, Bio-Rad Laboratories, Inc. launched the PTC Tempo 48/48 and PTC Tempo 384 thermal cyclers that are designed to aid PCR applications such as sequencing, cloning, and genotyping.In August 2023, F. Hoffmann-La Roche Ltd launched the Cobas Connection Modules (CCM) sample conveyor systems to enable flexibility in laboratory designs.In July 2023, Agilent Technologies, Inc. launched the BioTek Gen6 Software, which is used for all BioTek detection instruments. This software also provides an intuitive user interface that offers complete control of BioTek microplate readers for absorbance, fluorescence, and luminescence measurements for endpoint and kinetic assays.In July 2023, Thermo Fisher Scientific, Inc. launched the Diomni Enterprise Software, which provides a digital platform to support testing workflows in order to accommodate rapidly evolving needs.In July 2023, Bio-Rad Laboratories launched the IH-500TM NEXT System, a fully automated system for use with Bio-Rad’s ID Cards for routine testing and specialized testing such as newborn screening.In February 2023, Revvity, Inc. launched the EnVision Nexus Multimode Microplate Reader, which provides high-throughput screening and accelerates drug discovery results.In February 2023, Beckman Coulter Life Sciences collaborated with Sciex (U.S.) to provide comprehensive workflows for high-throughput screening HT-ADME and synthetic biology studies. The Echo MS System, which is based on Sciex’s Acoustic Ejection Mass Spectrometry technology, is now compatible with Beckman’s Echo Liquid Handlers.In February 2023, Tecan Group Ltd. collaborated with Element Biosciences, Inc. (U.S.) to offer a true benchtop NGS workflow with the MagicPrep NGS and AVITI System. This collaboration was aimed at enabling the direct conversion of NGS libraries without affecting sample quality.In June 2022, Beckman Coulter Life Sciences launched the Biomek NGeniuS liquid handling system to automate the labor-intensive process of manual library construction and reagent transfers. The system also eliminates loading errors.In April 2022, Revvity, Inc. collaborated with Scitara Corporation (U.S.) to integrate PerkinElmer’s Signals Research Suite informatics platform and Scitara’s iPaaS universal connectivity solution to facilitate fully connected laboratories along with standard data integrity, data mobility, system flexibility, and user reconfigurability.The report provides a competitive dashboard summarizing the market positioning of the 20 profiled market players in four quadrants, namely Industry Leaders, Differentiators, Emerging Companies, and Vanguards. These companies are positioned based on various parameters, including revenue, depth of offerings, brand equity, geographic presence, innovation, and organic & inorganic growth strategies. Thermo Fisher Scientific, Inc. (U.S), Danaher Corporation (U.S.), F. Hoffmann-La Roche AG (Switzerland), Hamilton Company (U.S.), Abbott Laboratories (U.S.), and Siemens Healthineers AG (Germany) are positioned in the industry leaders quadrant.
IMMEDIATE DELIVERY AVAILABLE | BUY THIS RESEARCH REPORT (Insights, Charts, Tables, Figures and More)- https://www.meticulousresearch.com/Checkout/13937383
Scope of the Report:
Lab Automation Market Assessment–by Product
SystemsAutomated Liquid Handling SystemsAutomated Nucleic Acid Purification SystemsAutomated ELISA SystemsAutomated Microplate ReadersAutomated Storage & Retrieval SystemsOther Lab Automation SystemsSoftwareLaboratory Information Management Systems (LIMS)Electronic Lab Notebook (ELN)Workstation/Equipment Automation SoftwareScientific Data Management Systems (SDMS)Lab Automation Market Assessment–by Application
Drug DiscoveryClinical DiagnosticsGenomics & Proteomics ResearchOther Applications(Note: Other applications include bioprocessing in biotechnology, cell analysis, basic research, forensic analysis, and quality control in the F&B industry.)
Lab Automation Market Assessment–by End User
Pharmaceutical & Biotechnology CompaniesHospitals & Diagnostic LaboratoriesAcademic & Research InstitutesOther End Users(Note: Other end users include the food & agriculture industries, forensic laboratories, blood banks, and environmental & quality testing laboratories.)
Lab Automation Market Assessment–by Geography
North AmericaU.S.CanadaEuropeGermanyU.K.FranceItalySpainRest of Europe (RoE)Asia-Pacific (APAC)ChinaJapanIndiaRest of APAC (RoAPAC)Latin AmericaMiddle East & AfricaBrowse More Related Reports:
Lab Automation Market is projected to hit $11.31 billion by 2031, growing at CAGR of 7.3% from 2024. Discover trends and growth factors driving this sector. – https://www.meticulousresearch.com/product/lab-automation-market-1221
Clinical Lab Automation Market is expected to reach $4.01 billion by 2031, at a CAGR of 7.8% from 2024 to 2031. – https://www.meticulousresearch.com/product/clinical-lab-automation-market-5762
Electronic Lab Notebook Market is expected to grow at a CAGR of 7.1% to reach $787.7 million by 2029. – https://www.meticulousresearch.com/product/electronic-lab-notebook-eln-market-4341
NGS Automation Market is expected to grow at a CAGR of 13.4% from 2022–2029 to reach $1.33 billion by 2029. – https://www.meticulousresearch.com/product/ngs-automation-market-5271
Explore future of  Industrial Automation Software Market, projected to hit $59.5 billion by 2029.  – https://www.meticulousresearch.com/product/industrial-automation-software-market-5279
Pharmaceutical Automation Market, valued at $11.16 Bn in 2023, is projected to reach $25.11 Bn by 2031, growing at a 10.8% CAGR from $12.21 Bn in 2024. – https://www.meticulousresearch.com/product/pharmaceutical-automation-market-5280
Lab-grown Meat Market is projected to reach $1.99 billion by 2035, at a CAGR of 21.4% during  forecast period of 2025–2035. – https://www.meticulousresearch.com/product/lab-grown-meat-market-5293
North America Electronic Lab Notebooks Market is projected to reach $372.7 million by 2030, at a CAGR of 6.8% from 2024 to 2030. – https://www.meticulousresearch.com/product/north-america-electronic-lab-notebook-market-5604
Europe Electronic Lab Notebook (ELN) Market is projected to reach $264.3 million by 2030, at a CAGR of 7% from 2024 to 2030. – https://www.meticulousresearch.com/product/europe-electronic-lab-notebook-market-5683
Pharmacy Automation Market is expected to reach $7.87 billion by 2030, at a CAGR of 7.6% during forecast period 2024–2030. – https://www.meticulousresearch.com/product/pharmacy-automation-market-5700
Life science equipment market is projected to reach $97.96 billion by 2031, at a CAGR of 6.3% from 2024 to 2031 – https://www.meticulousresearch.com/product/life-science-equipment-market-3937
Europe NGS automation Market to be worth $380.4 million by 2030, growing at a 13.4% CAGR from 2024 to 2030. – https://www.meticulousresearch.com/product/europe-ngs-automation-market-5644
North America NGS Automation Market is expected to reach $776.1 million by 2030, at a CAGR of 14% during  forecast period 2024–2030 – https://www.meticulousresearch.com/product/north-america-ngs-automation-market-5736
Asia-Pacific NGS Automation Market is expected to reach $371 million by 2031 at a CAGR of 16.3% from 2024 to 2031 – https://www.meticulousresearch.com/product/asia-pacific-ngs-automation-market-5790
Lab Automation Market Research Summary
Particular
Details
Page No
244
Format
PDF
Forecast Period
2024-2031
Base Year
2023
CAGR
7.30 %
Market Size (Value)
$11.31 billion
Market Size (Volume)
NA
Countries Covered
North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, RoE), Asia-Pacific (China, Japan, India, RoAPAC), Latin America, and the Middle East & Africa.
Key Companies
Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), F. Hoffmann-La Roche AG (Switzerland), Siemens Healthineers AG (Germany), Abbott Laboratories (U.S.), Becton, Dickinson, and Company (U.S.), Hudson Robotics, Inc. (U.S.), Hamilton Company (U.S.)
Click here to: Get Free Sample Pages of this Report
Hot Industry Reports: Emerging Trends and Market Forecasts
Veterinary Practice Management Software Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/veterinary-practice-management-software-market-1432
Asia Pacific Orthodontics Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/asia-pacific-orthodontics-market-4978
Feed Software Market by Size, Share, Forecast, & Trends Analysis – https://www.meticulousresearch.com/product/feed-software-market-2639
Point-of-care Diagnostics Market Size & Trends Analysis 2030 – https://www.meticulousresearch.com/product/point-of-care-diagnostics-market-4871
Soluble Dietary Fibers Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/soluble-dietary-fibers-market-3953
Genomics Market: Size, Trends & Global Forecast to 2031 – https://www.meticulousresearch.com/product/genomics-market-1262
Healthcare Gamification Market Size, Share, & Growth 2030 – https://www.meticulousresearch.com/product/healthcare-gamification-market-2592
3D Cell Culture Market Size & Growth Insights 2024-2030 – https://www.meticulousresearch.com/product/3d-cell-culture-market-1246
South East Asia Collagen Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/south-east-asia-collagen-market-3634
Next Generation Sequencing Informatics (NGS) Market Size, Share, Forecast, & Trends Analysis – https://www.meticulousresearch.com/product/ngs-informatics-market-3483
Recombinant Coagulation Factors Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/recombinant-coagulation-factors-market-1254
Crop Protection Chemicals Market Size, Share, Report, & Trends 2031 – https://www.meticulousresearch.com/product/crop-protection-chemicals-market-2584
Integrated Pest Management (IPM) Pheromones Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/integrated-pest-management-pheromones-market-5211
Sports Medicine Market: Size, Share, Forecast & Trends – https://www.meticulousresearch.com/product/sports-medicine-market-1215
MRI Infrastructure Capacity Assessment by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/mri-infrastructure-capacity-assessment-1217
Digital X-ray Systems Market Size, Share, Forecast, & Trends – https://www.meticulousresearch.com/product/digital-x-ray-systems-market-1183
Sports Technology Market Size, Trends & Forecast to 2030 – https://www.meticulousresearch.com/product/sports-technology-market-5584
Home Healthcare Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/home-healthcare-market-1280
Next Generation Sequencing Market Size, Share & Trends 2023-2030 – https://www.meticulousresearch.com/product/next-generation-sequencing-market-5040
Cloud Analytics Market Insights: Size, Share & Trends – https://www.meticulousresearch.com/product/cloud-analytics-market-5208
Home Medical Equipment Market by Size, Share, Forecast, & Trends Analysis – https://www.meticulousresearch.com/product/home-medical-equipment-market-1284
IoT in Healthcare Market Size, Share, & Trends 2031 – https://www.meticulousresearch.com/product/iot-in-healthcare-market-4945
Surgical Sutures Market by Size, Share, & Trends 2030 – https://www.meticulousresearch.com/product/surgical-sutures-market-4947
Lab Automation Market: Share, Trends & Forecast Analysis – https://www.meticulousresearch.com/product/lab-automation-market-1221
Asia Pacific EV Battery Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/asia-pacific-ev-battery-market-5217
Medical Imaging Market: Products, Applications, & Forecasts – https://www.meticulousresearch.com/product/medical-imaging-market-4950
Medical Ceramics Market by Size, Share, Forecast, & Trends Analysis – https://www.meticulousresearch.com/product/medical-ceramics-market-5538
Pharmaceutical Packaging Market Size, & Trends 2031 – https://www.meticulousresearch.com/product/pharmaceutical-packaging-market-5298
Ultrasound Market by Size, Share, Forecasts, & Trends Analysis – https://www.meticulousresearch.com/product/ultrasound-market-4972
Tissue Diagnostics Market Insights: Size, Trends & Forecast – https://www.meticulousresearch.com/product/tissue-diagnostics-market-4971
Contact:Mr. Khushal BombeMeticulous Market Research Inc.1267 Willis St, Ste 200 Redding,California, 96001, U.S.USA: +1-646-781-8004Europe: +44-203-868-8738APAC: +91 744-7780008Email- [email protected] Our Website: https://www.meticulousresearch.com/Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Meticulousblog.org | Top Market Research Reports Blog – https://meticulousblog.org/Content Source: https://www.meticulousresearch.com/pressrelease/967/lab-automation-market
Photo: https://mma.prnewswire.com/media/2506511/Lab_Automation_Market.jpgLogo: https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/lab-automation-market-to-reach-11-31-billion-by-2031–driven-by-rising-pharmaceutical–biotech-rd-expenditures-and-increasing-demand-for-automated-laboratories-and-instruments—report-by-meticulous-research-302249256.html

Continue Reading

Artificial Intelligence

Agoric and Noble Partner to Deliver Fast USDC For Rapid Transfers Powered by Orchestration

Published

on

agoric-and-noble-partner-to-deliver-fast-usdc-for-rapid-transfers-powered-by-orchestration

ORINDA, Calif., Sept. 16, 2024 /PRNewswire/ — Agoric, a layer 1 blockchain designed for multi-chain orchestration, announced today a strategic partnership with Noble, the premier RWA issuance chain in the modular ecosystem, to build Fast USDC. This new solution will dramatically reduce wait times when transferring USDC from Ethereum and other EVM-compatible chains into the Cosmos ecosystem when using the Noble Express application. By streamlining the process, Fast USDC enhances the user experience and accelerates onboarding for Web3 services.

Stablecoins, valued today at over $100 billion, has proven recently to be a Web3 killer app, and Circle has taken the lead in driving inter-blockchain transfers with their Cross-Chain Transfer Protocol (CCTP) to help reduce friction, increase safety, and reduce costs when sending USDC from one blockchain to another. Agoric relies on this transfer protocol, but builds on that with a Fast USDC solution.
One of the persistent challenges in the Web3 economy has been the slow and complex process of transferring assets across different blockchain networks, creating barriers to user adoption and growth. Traditional cross-chain transfers, particularly involving USDC, can take upwards of 20 minutes, a delay driven by finality challenges on some blockchains that can degrade the experience for users accustomed to instant transactions.
Fast USDC: A Faster, Smoother Experience
Fast USDC addresses this challenge head-on by leveraging Noble’s minimalist architecture to enable cross-chain transfers from Ethereum and other EVM chains to Cosmos chains. Fast USDC utilizes an on-chain Agoric Orchestration contract which interacts with accounts on the Noble chain, facilitating a verifiable flow of funds. Through an innovative settlement model, users can receive USDC almost instantly, reducing transfer times from as much as 20 minutes down to less than 2 minutes.
Fast USDC is more than just a faster way to move funds—it is a critical step toward achieving chain abstraction. For developers, Fast USDC is a building block that can be embedded into Agoric Orchestration contracts that provide deeper specific user experiences across many chains with only a single user signature. This will unlock experiences that bring in far greater adoption of blockchain-based applications.
Key Features and Benefits:
Rapid Transfers and Orchestration: The solution reduces transfer times of USDC from EVM chains to Cosmos by 10x, bringing usability of Web3 solutions closer to the seamless flows of any mainstream application.Enhanced User Experience: With FastUSDC, users will be able to onboard their USDC into Cosmos chains and apps while they wait, improving their experience and enhancing user retention.Decentralized and On-Chain: Thanks to the programmability of Agoric Orchestration, Fast USDC assets are managed entirely on-chain to ensure transparency, a necessity for mainstream adoption.”Fast USDC is a key use case showcasing the unmatched cross-chain programmability of Agoric Orchestration. It demonstrates how orchestration can solve critical challenges for Web3 users and applications,” said Dean Tribble, CEO at Agoric Systems. “Our collaboration with Noble is a testament to our shared vision of simplifying blockchain technology to drive mainstream adoption.”
“Fast USDC is an exciting use case that leverages Noble’s unique architecture and we are thrilled to partner with the Agoric team on this important initiative,” said Jelena Djuric, CEO at Noble.
Availability
Fast USDC will soon be available across major blockchain platforms, providing developers and users with a powerful tool to enhance the speed and usability of their decentralized applications. This partnership marks a significant step forward in the mission to make Web3 experiences accessible and user-friendly.
For more information about Fast USDC and how it fits into Agoric’s orchestration solutions and Noble’s RWA framework, please visit agoric.com and noble.xyz.
Dean Tribble, CEO of Agoric Systems, and Jelena Djuric, CEO of Noble, are available for interview
About Agoric
Agoric is a layer 1 blockchain for orchestration. In the fragmented blockchain landscape, Agoric brings orchestration to Web3 to solve the chain abstraction challenge and foster composability and true interoperability that unlock a new era of universal liquidity. Agoric is the brainchild of renowned computer scientists, Dean Tribble and Mark Miller. Their groundbreaking work in secure computing and distributed systems laid the foundation for Agoric’s innovative technology.
About Noble
Noble is the premier asset issuance chain in the modular ecosystem. Noble solves a variety of critical pain points around native issuance, including security, liquidity, compliance, standardization and neutrality. Noble’s long-term vision is to be a UX unlock for all stablecoin and RWA issuers.
Press Contact: Alissa Karpick, Wachsman, E: [email protected]
 

View original content:https://www.prnewswire.co.uk/news-releases/agoric-and-noble-partner-to-deliver-fast-usdc-for-rapid-transfers-powered-by-orchestration-302249013.html

Continue Reading
Advertisement
Advertisement

Latest News

Trending